Lv3
348 积分 2024-04-17 加入
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial
17小时前
已完结
Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma
17小时前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
15天前
已完结
CAR-X cell engineering
1个月前
已完结
Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo
3个月前
已完结
Orthogonal Design of Experiments for Optimization of Lipid Nanoparticles for mRNA Engineering of CAR T Cells
3个月前
已完结
Preparation of targeted lipid nanoparticles for precision nucleic acid delivery
3个月前
已完结
Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity
3个月前
已完结
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
4个月前
已完结
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
4个月前
已完结
皖公网安备34019202002308
